drugset / Trial / NCT00401869

The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study)

NCT00401869 ↗

Phase 4 Completed 289 enrolled Ortho Biotech, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to compare the effect of epoetin alfa to preoperative autologous blood donation (PAD) on postoperative vigor (a measure of functional ability and well-being) and handgrip strength in patients undergoing hip or knee surgery.

Timeline

Start
1999-02
Primary completion
—
Completion
2001-12

Outcome

Missed primary endpoint

paper Mean changes in vigor score and handgrip strength from baseline were not significantly different between treatment groups. PMID 17400086 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic 600 iu/kg Subcutaneous

Indications